
    
        <!DOCTYPE html>
        <html lang="hu-HU" data-website-id="1" data-oe-company-name="HBS Medical">
            
<!-- Mirrored from hbs.hu/slides/slide/hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 16:04:22 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
                <meta charset="utf-8"/>
                <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
                <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no"/>

                <title>Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063 | HBS</title>
                <link type="image/x-icon" rel="shortcut icon" href="../../web/image/website/1/favicon/index.html"/>

                <script type="text/javascript">
                    var odoo = {
                        csrf_token: "f2e9a41588799d043a772b21ddc3189150ea199fo",
                    };
                </script>

                
            <meta name="generator" content="Odoo"/>

            
            
            
            
            
            
                
                
                
                    
                        <meta property="og:type" content="website"/>
                    
                        <meta property="og:title" content="Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063"/>
                    
                        <meta property="og:site_name" content="HBS Medical"/>
                    
                        <meta property="og:url" content="https://hbs.hu/slides/slide/hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34"/>
                    
                        <meta property="og:image" content="https://hbs.hu/web/image/slide.slide/34/image_thumb"/>
                    
                        <meta property="og:description"/>
                    
                
                
                
                    
                        <meta name="twitter:card" content="summary_large_image"/>
                    
                        <meta name="twitter:title" content="Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063"/>
                    
                        <meta name="twitter:image" content="https://hbs.hu/web/image/slide.slide/34/image_thumb"/>
                    
                        <meta name="twitter:description"/>
                    
                
            

            
            
                
                    <link rel="alternate" hreflang="hu" href="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html"/>
                
            

            <script type="text/javascript">
                odoo.session_info = {
                    is_admin: false,
                    is_system: false,
                    is_frontend: true,
                    translationURL: '/website/translations',
                    is_website_user: true,
                    user_id: 4
                };
                
            </script>

            <link type="text/css" rel="stylesheet" href="../../web/content/521-3ab7b2c/1/web.assets_common.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/599-e81acc7/1/web.assets_frontend.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/600-e81acc7/1/web.assets_frontend.1.css"/>
            
            
            

            <script type="text/javascript" src="../../web/content/524-3ab7b2c/1/web.assets_common.js"></script>
            <script type="text/javascript" src="../../web/content/603-e81acc7/1/web.assets_frontend.js"></script>
            
            
            
        
            </head>
            <body>
                
            
        
            
        
        
            
                
                    
                
                
            
        
        
    
    

            
            
        
    
            
          
        <link rel="stylesheet" type="text/css" href="../../sh_cookie_notice/static/src/css/cookieconsent.min.css"/>
        <script type="text/javascript" src="../../sh_cookie_notice/static/src/js/cookieconsent.min.js"></script>
        

	
	<script type="text/javascript"> 

	 window.addEventListener("load", function(){
 
	var sh_msg = String("Az HBS weboldala sütiket használ a weboldal működtetése, használatának megkönnyítése, a weboldalon végzett tevékenység nyomon követése és releváns ajánlatok megjelenítése érdekében.");
	var sh_esc_msg = encodeURIComponent(sh_msg);
	sh_esc_msg = decodeURIComponent(sh_esc_msg); 
	
  	window.cookieconsent.initialise({
	  "palette": {
	    "popup": {
	      "background": "#000" 
	    },
	    "button": {
	      "background": "#f1d600"
	    }
	  },
	  
	  	  "position": "top",
	  
	
	  
	  "content": {
	    "message": sh_esc_msg,
	    "dismiss": "Elfogadom",
	    "allow": "allow",
	    "link": "Adatvédelmi tájékoztató",
	    "href": "/adatkezelesi-tajekoztato"
	  }
	})});
    </script>
 
   
    <div id="wrapwrap" class="   ">
                <header class=" o_affix_enabled">
                    <nav class="navbar navbar-expand-md navbar-light bg-light">
                        <div class="container">
                            <a href="../../index.html" class="navbar-brand logo">
            <span role="img" aria-label="Logo of HBS Medical" title="HBS Medical"><img src="../../web/image/res.company/1/logo66cf.png?unique=866a03a" class="img img-fluid"/></span>
        </a>
    <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#top_menu_collapse">
                                <span class="navbar-toggler-icon"></span>
                            </button>
                            <div class="collapse navbar-collapse" id="top_menu_collapse">
                                <ul class="nav navbar-nav ml-auto text-right o_menu_loading" id="top_menu">
                                    
        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../index.html" class="nav-link ">
            <span>HBS Medical</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="https://covid-19.hbs.hu" class="nav-link " target="_blank">
            <span>COVID-19</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../blog/hirek-esemenyek-1.html" class="nav-link ">
            <span>Hírek</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../aboutus.html" class="nav-link ">
            <span>Kapcsolat</span>
        </a>
    </li>
    

        
    
                                    
                                </ul>
                            </div>
                        </div>
                    </nav>
                </header>
                <main>
                    
        
        <div class="container mt16">
            <div class="row">
                <div class="col-xl-8 col-lg-8 col-md-12 col-12">
                    

                    <div>
                            
                        <div class="embed-responsive embed-responsive-4by3 embed-responsive-item mb8">
                            <iframe src="../embed/342679.html?page=1" class="o_wslides_iframe_viewer" allowFullScreen="true" height="315" width="420" frameborder="0"></iframe>
                        </div>
                        
                        <div class="row">
                            <h4 class="col-lg-6">Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063</h4>
                            <div class="col-lg-6">
                                <div clas="row">
                                    
                                </div>
                            </div>
                        </div>
                        <div class="row">
                            <div class="col-md-8 col-12">
                                <div class="float-left">
                                    <a href="../nyilvanos-anyagok-1.html" title="Channel Nyilvános anyagok" aria-label="Channel Nyilvános anyagok">
                                        <i class="fa fa-circle-o fa-5x" style="color: #875A7B;font-weight: bold;"></i>
                                    </a>
                                </div>
                                <div style="margin-left: 80px">
                                    <p>
                                        <a href="../nyilvanos-anyagok-1.html">Nyilvános anyagok</a>
                                        
                                            <span> / </span>
                                            <a href="../nyilvanos-anyagok-1/category/szakirodalmi-cikkek-3.html">Szakirodalmi cikkek</a>
                                        
                                    </p>
                                    <div>
                                        
        <div class="input-group js_follow" data-id="1" data-object="slide.channel" data-follow="off">
            <input type="email" name="email" class="js_follow_email form-control" placeholder="emailje..."/>
            <div class="input-group-append">
                <button href="#" class="btn btn-secondary js_unfollow_btn">Leiratkozás</button>
                <button href="#" class="btn btn-primary js_follow_btn">Feliratkozás</button>
            </div>
        </div>
    
                                    </div>
                                </div>
                            </div>
                            <div class="col-md-4 d-none d-md-block">
                                <div class="text-right">
                                    <b class="h3 text-muted">1310</b> <span class="text-muted small">views</span>
                                </div>
                                
                                <div class="progress mb0" style="height: 2px;">
                                    <div class="progress-bar" role="progressbar" aria-valuenow="0" aria-valuemin="0" aria-valuemax="100" style="width: 0%;">
                                        <span class="sr-only">0 Likes</span>
                                    </div>
                                </div>
                                <div class="text-muted mt4">
                                    <div class="float-right mb16 text-right">
                                        <span class="oe_slide_js_like" data-href="/slides/slide/like" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="34">
                                            <i class="fa fa-thumbs-up fa-1x" role="img" aria-label="Likes" title="Likes"></i>
                                            0
                                        </span>
                                        <span class="oe_slide_js_unlike" data-href="/slides/slide/dislike" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="34">
                                            <i class="fa fa-thumbs-down fa-1x" role="img" aria-label="Dislikes" title="Dislikes"></i>
                                            0
                                        </span>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="mt8 mb32">
                            <ul class="nav nav-tabs" role="tablist">
                                <li class="nav-item">
                                    <a href="#about" aria-controls="about" role="tab" data-toggle="tab" class="nav-link active">
                                        <i class="fa fa-home"></i> About
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#share" aria-controls="share" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-share-alt"></i> Share
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#discuss" aria-controls="discuss" role="tab" data-toggle="tab" class="nav-link">
                                        <i class="fa fa-comments-o"></i> Comments
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#transcript" aria-controls="transcript" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-align-justify"></i> Transcript
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#statistic" aria-controls="statistic" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-bar-chart"></i> Statistics
                                    </a>
                                </li>
                            </ul>
                            <div class="tab-content" style="padding: 20px 5px 5px 5px; word-wrap: break-word;">
                                <div role="tabpanel" id="about" class="tab-pane fade active in">
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="share">
                                    
    <h4 class="mt0">Share on Social Networks</h4>
    
    <div>
        <a class="o_slides_social_share" social-key="facebook" aria-label="Share on Facebook" title="Share on Facebook" href="https://www.facebook.com/sharer/sharer.php?u=https://hbs.hu/r/qON"><i class="fa fa-facebook-square fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="twitter" aria-label="Share on Twitter" title="Share on Twitter" href="https://twitter.com/intent/tweet?text=Hyaluronic%20Acid%20and%20Its%20Composites%20as%20a%20Local%20Antimicrobial-Antiadhesive%20Barrier%202017.jbjiv02p0063&amp;url=https://hbs.hu/r/qON"><i class="fa fa-twitter fa-2x"></i></a>
        <a social-key="linkedin" class="o_slides_social_share" aria-label="Share on LinkedIn" title="Share on LinkedIn" href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://hbs.hu/r/qON&amp;title=Hyaluronic%20Acid%20and%20Its%20Composites%20as%20a%20Local%20Antimicrobial-Antiadhesive%20Barrier%202017.jbjiv02p0063&amp;"><i class="fa fa-linkedin fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="gplus" aria-label="Share on Google Plus" title="Share on Google Plus" href="https://plus.google.com/share?url=https://hbs.hu/r/qON"><i class="fa fa-google-plus-square fa-2x"></i></a>
    </div>

    <h4 class="mt-3">Share Link</h4>
    <input type="text" class="form-control" readonly="readonly" onClick="this.select();" value="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html"/>
    <span class="form-text">Use permanent link to share in social media</span>

                                    
    <h4 class="mt-3">Share with a friend</h4>
    
    
        <p>Please <a href="../../web/login.html?redirect=https://hbs.hu/slides/slide/hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34"> login </a> to send this document by email!</p>
    

                                    
                                        
    <div class="oe_slide_js_embed_code_widget">
        <h4 class="mt0">Embed in your website</h4>
        <div class="form-group">
            <textarea class="form-control slide_embed_code" readonly="readonly" onClick="this.select();">&lt;iframe src=&quot;https://hbs.hu/slides/embed/34?page=1&quot; class=&quot;o_wslides_iframe_viewer&quot; allowFullScreen=&quot;true&quot; height=&quot;315&quot; width=&quot;420&quot; frameborder=&quot;0&quot;&gt;&lt;/iframe&gt;</textarea>
        </div>
        <div class="form-group">
            <div class="form-text col-xl-3 col-lg-3 col-md-6 col-6">Select page to start with</div>
            <div class="input-group col-xl-3 col-lg-3 col-md-6 col-6">
                <input type="number" value="1" class="form-control"/>
            </div>
        </div>
    </div>

                                    
                                </div>
                                
                                <div role="tabpanel" id="discuss" class="tab-pane fade">
                                    
        <div id="discussion" class="d-print-none o_portal_chatter o_not_editable p-0" data-res_model="slide.slide" data-res_id="34" data-pager_step="10" data-allow_composer="1">
        </div>
    
                                </div>
                                <div role="tabpanel" class="tab-pane fade oe_slides_transcript" id="transcript">
                                    
                                        
                                            <p>2.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   64   low probability of bacteria l attachment if host cells  adhere to implant first, and vice versa. In the event of  bacterial adhesion to an implant, immediate biofilm  formation starts, making the bacteria resistant to host  defense mechanisms [8].   In addition, the matrix protects the bio film cells  from various microbicidal agents and stresses,  including dehydration, toxins, ultraviolet light,  chemical disinfectants, temperature and osmotic  shock, and lead them to increased resistance against  antimicrobials [9, 10].   To address the limited  efficacy of existing  antibiotics in the treatment of established bacterial  biofilms, novel approaches are required to prevent  bacterial adhesion and biofilm formation [11].    Adhesion is a necessary first step in microbial  colonization and pathogenesis and  provides a good  theoretical target for new preventive and treatment  strategies [12].   Bacterial adhesion to surfaces can be divided  into a first, reversible phase and a second, irreversible  phase. The first bacterial adhesion occurs between  bacterial adhesi ns and surface receptor sites [13].    Once an implant is inserted into the body, it is  covered by a conditional protein layer composed of  host proteins, such as albumin and complement, that  act as a reservoir of several receptors for bacterial  adhesive liga nds, mediating adhesion of free - floating  bacteria to the surface of the biomaterials [14, 15];  these first adhesions are, however mechanically and  biologically unstable.    Few minutes  after   this first, reversible phase,  bacterial clusters attached to the su rface starts to  express biofilm related genes, produce glycocalyx and  form mature biofilm, thus transforming the adhesion  from reversible to irreversible [16].    Full - formed biofilm can be found few hours after  the first bacterial adhesion [17].    Antimicrob ial surface coatings can be based on  an anti - adhesive principle that prevents bacteria to  adhere and form biofilms [18].    In fact, some polymer coatings, like the  hydrophilic polymethacrylic acid, polyethylene oxide  or protein - resistant polyethylene glycol   can be  applied to the surface of titanium implants and result  in significant inhibition of bacterial adhesion [19  –   22].    Hydrophobic and superhydrophobic surface  treatment technologies have also shown a great  repellent antibacterial effect in preclinical   studies [23  –   25].    However, clinical application of completely  novel coating technologies and compounds, not  otherwise previously tested in humans, appears  particularly challenging [26].   Bacterial colonization can also be blocked by an  inhibitor interfering with ligand – receptor interaction  for bacterial attachment. One of these inhibitors could  be Hyaluronic Acid (HA), a glycosaminoglycan made  up of glucuronic acid and N - acetylglucosamine  disaccharide units. It is a uniform, linear and  unbranched molecule, with highly variable length  and molecular weight (up to 106 Da). It is abundant in  skin (up to 56%) and in connective tissues, with a  turnover ranging from several hours to a few days  dep ending on tissues.    Hyaluronic acid constitutes one of the main  components of extracellular matrices. Because of its  biological properties, HA has several clinical  applications (aesthetic surgery, dermatology,  dentistry, orthopedics and opthalmology) [27].   Extensive studies on the chemical and  physicochemical properties of HA and its  physiological role in humans, together with its  versatile properties, such as its biocompatibility,  non - immunogenicity, biodegradability, and  viscoelasticity, have proved that  it is an ideal  biomaterial for medical and pharmaceutical  applications [28, 29].   Among its various properties, several studies  have recently shown the ability of HA to protect  against various infectious agents [30], depending on  HA concentration and molecu lar weight [31, 32],  while more recently HA interference on bacterial  adhesion and biofilm formation has been extensively  investigated [33].    Given its high biocompatibility and well known  safety profile and the anti - adhesive capabilities, HA  and its compo sites represent an attractive,  non - antibiotic, option to mitigate the impact of  biofilm - related infections in various clinical settings  including implant - related infections.    Aim of this review is to provide an update of the  current evidence concerning HA  ability to  reduce/prevent bacterial adhesion and biofilm  formation.     Anti - adhesive and anti - biofilm properties  of hyaluronic acid and its composites   Nearly two decades ago, Pavesio et al. [34] were  probably the first to describe the ability of HA to resist   bacterial adhesion, with particular reference to  Staphylococcus epidermidis,   and its non - fouling  properties [35], proposing coated polymeric medical  devices (e.g., intraocular lenses, stents and catheters)  to reduce implant - related infections.   In particul ar, a   hydrophilic HA overlayer, linked  to the surface of  p olymethylmethacrylate intraocular  lenses (IOLs), was shown to be able to   prevent  fibroblasts adhesion and to greatly reduce  </p>
                                        
                                            <p>4.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   66   Antibacterial Coating”, DAC ® , Novagenit Srl,  Mezzolombardo, Italy), has been found to have a  synergistic antibiofilm activity with various  antibacterials and able to be effective ly manually  spread onto the surface of various biomaterials  commonly used in  orthopaedics, trauma and dental  surgery  [43] (Fig. 1).        Figure 1.  DAC ®   hydrogel application on a titanium acetabular cup prosthesis (A).  The hydrogel comes in powder form in a prefilled syringe and is designed to be  reconstituted at the time of surgery with water for injection.  Scanning Electron  Microscope ( SEM) analysis of  sandblasted titanium samples surface (magnification  10,000x) without the hydrogel coating (B) or after DAC ®   coating (C) and mechanical  scraping of the hydrogel to test its ability to resist press - fit insertion. Note the  complete and uniform coverage of the   titanium surface.   The ability to completely cover even  sand - blasted titanium surface and resist scraping has  in fact been confirmed by scanning electron  microscopy (SEM) analysis (cf. Fig. 1). This is an  important requirement in order to reduce the expose d  surface of a biomaterial, thus creating  a   uniform  coating of the surface and leaving no pores or cracks  that could eventually be colonized by planktonic  bacteria.    In unpublished experiments (Novagenit Srl, data  on file), in order to evaluate DAC ®   abilit y to prevent  bacterial adhesion, 200 mg of hydrogel were  homogenously spread on the surface of sterile  titanium discs. Hydrogel - coated substrates and  uncoated substrates (controls) were then placed into  sterile 6 - wells polystyrene plates and overlaid with  a  standardized inoculum (10 8   CFU/mL) of bacterial  cells for 15, 30, 60 and 120 minutes. Afterwards,  non - adherent bacteria were removed by rinsing with  sterile saline. The remaining adhered cells were  detached by adding a solution of 0.1% w/v  dithiothreitol   (DTT) (Sigma - Aldrich, Milan, Italy) to  each well and stirring for 15 minutes at room  temperature. Then, 100 μL of each sample were plated  onto Tryptic Soy agar ( TSA; Merck, Darmstadt,  Germany ) and incubated at 37°C for 24 hours for CFU  counts. Ten discs w ere used for each condition and  each time interval.   The results showed that the adhesion density of  S. aureus   on titanium discs pre - treated with DAC ® ,  was significantly lower than adhesion on untreated  controls at each time point (Fig. 2). In particular,  reductions of adhered bacteria equal to 86.8%, 80.4%,  74.6% and 66.7% vs untreated discs were observed  after 15, 30, 60 and 120 minutes of incubation,   respectively, while an increase of adhesion density  during time was observed for both control and  pre - treated discs (Fig. 3).    Further analys e s were conducted to show the  ability to dislodge previously adhered bacteria; to this  aim, titanium discs were pl aced into sterile 6 - wells  polystyrene plates and overlaid with a standardized  inoculum (10 8   CFU/mL) of bacterial cells in order to  allow the adhesion of bacterial cells. Afterwards, 200  mg of hydrogel were spread on the surface of  contaminated titanium dis cs in order to remove  previously adhered bacteria. Contact times were 15,  30, 60 and 120 minutes. Untreated substrates were  used as controls. Non - adherent bacteria were  removed by rinsing with sterile saline, while the  remaining adhered cells were detached   by adding  0.1% DTT as previously described. Then, 100 μL of  each sample were plated onto TSA and incubated at  37°C for 24 hours for CFU counts. Ten discs were used  for each condition and each time interval.    </p>
                                        
                                            <p>8.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   70         Figure 6.   Comparison of the efficacy of DAC hydrogel, gentamicin, vancomycin or a combination thereof, on biofilm formation reduction o f  Staphylococcus aureus   (A. and B.) and  Staphylococcus epidermidis   (C. and D.) over time (hours).   Note that the hydrogel alone is able to provide an equal or superior biofilm reduction compared to commonly used  antibiotics, while a synergistic effect is observed using a combination of the hyaluronic acid based hydrogel a nd the antibiotic compounds.   </p>
                                        
                                            <p>7.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   69   controlled study,   otoscopy, tympanometry and  p ure - tone audiometry in children which received the  daily topical administration of normal 0.9% sodium  chloride saline solution (control group) or 9 mg of  sodium hyaluronate in 3 mL of a 0.9% sodium saline  solution was performed. The final analysis was base d  on 116 children (49.1% boys; mean age, 62.9 ± 17.9  months): 58 in the control group and 58 in the study  group. At the end of follow - up, the prevalence of  patients with impaired otoscopy was significantly  lower in the study group (P value = 0.024) compare d  to baseline but not in the control group. In comparison  with baseline, the prevalence of patients with  impaired tympanometry at the end of the follow - up  period was significantly lower in the study group (P  value = 0.047) but not in the control group. The   reduction in the prevalence of patients with  conductive hearing loss (CHL) (P value = 0.008) and  those with moderate CHL (P value = 0.048) was  significant in the study group, but not in the control  group. The mean auditory threshold had also  significantly   improved by the end of treatment in the  study group (P value = 0.004) but not in the control  group.    Several studies have also reported the beneficial  effect of topical HA in chronic urinary tract infections  (UTI). In contrast to traditional antibiotic th erapy,  which aims at eradicating pathogens, treatment with  HA targets bacterial adherence to the bladder mucosa  with the presumption that a damaged  glycosaminoglycan mucous layer facilitates bacterial  adherence and therefore recurrent UTI [46].   Among other s [47, 48], Lipovac and colleagues  evaluated the efficacy of nine HA bladder instillations  over 6 months in 20 women with a history of recurrent  UTI. Their status was assessed prospectively but  compared with a retrospective review of patients’  charts. The  number of infections per year per patient  was significantly reduced (from 4.99±0.92 to  0.56±0.82, p&gt;0.001) and the mean time to recurrence  (from 76.7±24.6 to 178.3±25.5 days, p&gt;0.001) was  prolonged significantly. Nevertheless 65% of  treated  patients were f ree of recurrences until the end of  study (47.6 weeks) [49].   Damiano et al. were able to provide a higher  level of evidence by reporting a prospective,  randomized, double - blind, placebo - controlled study,  in which a significant reduction of 77% (p&lt;0.0002) i n  the UTI rate per patient per year versus placebo was  observed at the end of the study. Moreover, mean  time to UTI recurrence was significantly prolonged  (185.2±78.7 versus 52.7±33.4 days, p&lt;0.001) after  treatment compared with placebo. Overall urinary  sy mptoms and quality of life measured by  questionnaires significantly improved compared with  placebo [50]. No adverse events were reported.   Very recently a multicentre European study  confirmed the efficacy of intravesical administration  of combined  hyaluronic acid and chondroitin  sulphate (CS) for the treatment of female recurrent  urinary tract infections [51]. A total of 276 adult  women received intravesical administration of  HA+CS or standard of care (antimicrobial/  immunoactive prophylaxis/ probio tics/cranberry).  At follow - up, 181 patients treated with HA+CS and 95  patients treated with standard of care from 7 centres  were available. The crude and adjusted ORs (95% CI)  for bacteriologically confirmed recurrence within 12  months were 0.77 (0.46 to 1 .28) and 0.51 (0.27 to 0.96),  respectively.   Studies were also undertaken to determine the  effect on clinical variables, sub - gingival bacteria and  local immune response brought about by application  of hyaluronan - containing gels in early wound healing  after  scaling and root planing (SRP) in dentistry [52,  53].    In the study reported from Eick et al. [54], 34  individuals with chronic periodontitis were evaluated  after full - mouth SRP. The exclusion criteria were:  antibiotics intake in the 6 months before the st udy,  periodontal treatment received during the previous  year, pregnancy, nursing, smoking, chronic diseases  such as diabetes mellitus or rheumatoid arthritis, and  allergy to ingredients in the drug. In the test group  (n=17), a 0.8% hyaluronan - containing ge ls (HA) was  introduced into all periodontal pockets during SRP  and a 0.2% HA gel was applied by the patients onto  the gingival margin twice daily during the following 2  weeks while the control group (n=17) was treated  with SRP only; no placebo was used.    P robing depth (PD) and clinical attachment level  (CAL) were recorded at baseline and after 3 and 6  months, and subgingival plaque and sulcus fluid  samples were taken for microbiologic and  biochemical analysis. In both groups, PD and CAL  were significantly r educed (P&lt;0.001).    The changes in PD and the reduction of the  number of pockets with PD≥5 mm were significantly  higher in the test group after 3 (P=0.014 and 0.021)  and 6 (P=0.046 and 0.045) months.    Six months after SRP, the counts of  Treponema  denticola   were  significantly   reduced in both groups  (both P=0.043), as were those of Campylobacter rectus  in the test group only (P=0.028).  Prevotella intermedia  and  Porphyromonas gingivalis   increased in the control  group. No adverse effects of HA were observed  duri ng the study.     </p>
                                        
                                            <p>6.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   68     Figure 5.   Adhesion densities over time on discs with  of  S. aureus   ( mean CFU/cm 2   ± standard deviation )  applied before DAC treatment and controls at  15, 30, 60, 120 min ; * 0.01  &lt; P &lt;0.05, ** 0.001 &lt; P &lt; 0.01, *** P &lt; 0.001 (two - way ANOVA followed by Bonferroni post hoc test).     Concerning more specifically the antibiofilm  activity,  DAC ®   hydrogel showed similar or superior  in   vitro   activity, compared to various antibacterials  and a synergistic activity when used in combination  (Fig. 6) [43]. In the experimental setting  S. epidermidis  and  S. aureus  were grown on chrome - cobalt devices in  6 - wells polystyrene plates containing TSB   for 24 hours  at 37°C. Then, growth medium was removed together  with non - adherent bacteria and new broth added. The  plates were incubated at 37°C in ambient air, until a  visible biofilm was obtained. Gentamycin and  vancomycin were tested at a final concent ration of 20  mg/mL. Similarly, when mixed with the hydrogel, 60  mg of gel powder were reconstituted with 1 mL of  water for injections containing gentamicin or  vancomycin at 20 mg/mL concentration.    Amount of biofilm at each time was determined  before hydro gel and antibiotic agents addition and  after 0.5, 1, 2, 4, 6, 24 and 48 hours of incubation by a  spectrophotometric assay. In particular, at each time,  broth was removed and biofilm stained with Crystal  Violet. The excess stain was then rinsed off with  dis tilled water and air - dried. After elution of the stain  from implants with absolute ethanol, the amount of  biofilm was quantified by reading optical density  (O.D.) at a wavelength of 595 nm against blank  (consisting of ethanol). Amount of biofilm at each  ti me was compared with that formed on the same  type of implant before treatment. Each assay was  performed in duplicate and repeated for three times.    At each time point, both for gentamycin and  vancomycin showed only a partial inhibition of  biofilm formation   (ca. 30  -   40% for gentamicin; ca. 40  -   50% for vancomycin), with minor difference between  the two studied microorganisms.   On the other side, the hydrogel alone resulted in  a significant reduction of biofilm of ca. 50% in  comparison to the untreated contro ls, while a  combination of the hydrogel with either antibacterial  resulted in a larger reduction of biofilm formation  (approximately 75 to 80% in comparison with  untreated controls).   Both these experimental studies show the ability  of the DAC ®   hydrogel to  significantly reduce bacterial  adhesion and biofilm formation of common bacterial  pathogens, thus potentially providing an effective  protection of the implant; however, these data also  point out how, in the clinical setting, in the absence of  an adequate i mmune response from the host and/or  of sufficient local levels of antibiotics, a passive  antiadhesive coating [18] like HA can be overcome by  the remaining bacteria in a time - dependent manner.  For this reason, any passive antiadhesive coating of  implants [ 44] should probably better be seen as a tool  to reduce and delay bacterial adhesion and biofilm  formation to a variable degree, also depending on the  local environment, the contaminating bacterial species  and initial bacterial load; this may still provide  an  additional advantage to the host’s cells to first  colonize the implanted biomaterial and win the  competition with the microorganisms that may  eventually be present, thus contributing to reduce the  occurrence of implant - related infections.   Clinical appli cations of hyaluronic acid to  prevent bacterial adhesion   Several clinical local applications of HA to  reduce the impact of biofilm - related infections have  been reported, in different clinical settings, with  favourable results and no adverse events.   Torrett a et al. [45] recently described topical  administration of  hyaluronic acid   in children with  recurrent or chronic middle ear inflammations and  chronic adenoiditis.    In this prospective, single - blind, randomised  </p>
                                        
                                            <p>1. J .   Bone Joint Infect .   20 1 7 ,  Vol.  2       http://www. jbji.net   63   J J o o u u r r n n a a l l     o o f f     B B o o n n e e     a a n n d d     J J o o i i n n t t     I I n n f f e e c c t t i i o o n n     201 7 ;   2 (1) :   63 - 72 .   doi: 10.7150/ jbji . 17705   Re view   Hyaluronic  Acid and Its Composites as  a   Local  Antimicrobial/Antiadhesive Barrier   C.L.   Romanò 1 ,  ,  E.  De Vecchi 3 ,  M.  Bortolin 3 ,  I .   Morelli 1 ,  L.   Drago 2, 3   1.   Department of Reconstructive Surgery of Osteo - articular Infections C.R.I.O. Unit, I.R.C.C.S. Galeazzi Orthopaedic Institute, Milano, Italy   2.   Laboratory of Technical Sciences for Laboratory Medicine, Department of Biomedical Sciences for Health, University of Milan,  Milan, Italy   3.   Laboratory of Clinical Chemistry and Microbiology, I.R.C.C.S. Galeazzi Orthopaedic Institute, Milan, Italy        Correspo nding author :   Dr. Carlo Luca Romanò, Department   of Reconstructive Surgery of Osteo - articular Infections ,  IRCCS,  Galeazzi Orthopaedic Institute  -   Via R. Galeazzi 4 20161 Milan, Italy .  Phone :  00390266214743; Fax: 00390266214774 ;   E - mail: <a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="e5868497898acb978a88848b8aa582979095958a96848b818a8b84918acb8c91">[email&#160;protected]</a>   © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY - NC) license  (https://creativecommons.org/licenses/by - nc/4.0/). See http://iv yspring.com/terms for full terms and conditions.   Published:  201 7 . 0 1 . 01   Abstract   Living in biofilms is probably the most common condition for bacteria and fungi and biofilm - related  infections account for the majority of bacterial infectious diseases worldwi de.    Among others biofilm - related infections, those associated with implanted biomaterials have  an   enormous and still largely underestimated impact in orthopaedics and trauma, cardio - surgery and  several other surgical disciplines.   Given the limited efficac y of existing antibiotics in the prevention and treatment of bacterial  biofilms, new strategies are needed to protect implants and host tissues, overcoming the striking  ability of the microorganisms to adhere on different surfaces and to immediately protec t  themselves by forming the biofilm matrix.   Adhesion is a necessary first step in microbial colonization and pathogenesis and provides a  potential target for new preventive and treatment approach.   Among various polymers, tested as antibacterial coatings, h yaluronic acid   and some of its  composites do offer a  well - established   long - term safety profile and a proven ability to reduce  bacterial adhesion and biofilm formation.     Aim of the present review is to summarize the available evidence concerning the  antiadh esion/antibiofilm activity of  hyaluronic acid   and some of its derivatives to reduce/prevent  bacterial adhesion and biofilm formation in various experimental and clinical settings.   Key words:  Hyaluronic Acid, Biofilm, Adhesion, Bacteria, Infection, Implant   Introduction   According to   the U.S. National Institutes of  Health, up to 80% of human bacterial infections  involve biofilm - associated microorganisms [1].   Among these, implant - related infections do still  have a tremendous impact in orthopaedics and  trauma [2], with high social and e conomic costs [3, 4],  posing challenging diagnostic and therapeutic  dilemmas [5].    In fact, peri - prosthetic joint infection (PJI)  remains one of the most feared complications in  orthopaedic surgery and among the first reasons for  implant failure [6].    More over, given the increasing number of hip  and kne e  arthroplasties  performed, the prevalence of  this complication is rising, with increasing costs for  national health systems and increasing biological  costs for the patients, such as loss or reduced joint  fun ction and deterioration in their physical and  psychological health [7].    According to the widely accepted model of the  ‘race for the surface’ for PJI development, host and  bacterial cells compete for surface colonization, with a      Ivyspring     International Publisher   </p>
                                        
                                            <p>5.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   67   The results showed that DAC® hydrogel  treatment   of discs reduced the amount of adhered  bacteria in respect to control discs after 15, 30, 60 and  120 minutes   of   84.0%, 72.8%, 72.3% and 64.3%,  respectively (Fig.4). Once again, an increase of  adhesion density during time was observed for both  control and  treated discs  (Fig. 5).       Figure 2.   Adhesion densities of  S. aureus   ( mean CFU/cm 2   ± standard deviation ) to discs pre - treated with  DAC ®   (“Defensive Antibacterial Coating”, Novagenit Srl,  Mezzolombardo, Italy)  and controls at 15, 30, 60 and 120 min;  *** P &lt; 0.001 (two - way ANOVA followed by Bonferroni post hoc test).      Figure 3.  Adhesion  densities  of  S. aureus   ( mean CFU/cm 2   ± standard deviation )  over time in pre - treated  with  DAC ®   and control discs  at 15, 30, 60,   120 min ; * 0.01 &lt; P &lt;0.05,  ** 0.001 &lt; P &lt; 0.01, *** P &lt; 0.001 (two - way ANOVA followed by Bonferroni post hoc test).     Figure 4.   Adhesion densities on discs with  of  S. aureus   ( mean CFU/cm 2   ± standard deviation )  applied before DAC treatment and controls at  15, 30, 60, 120 min; * 0.01 &lt; P &lt;0.05,  *** P &lt; 0.001 (two - way ANOVA followed by Bonferroni post hoc test).   </p>
                                        
                                            <p>3.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   65   Staphyloccous epidermidis   adhesion to the implant  surface [36].   The impact   of slime dispersants and  anti - adhesives on  in vitro   biofilm formation on IOLs  was further investigated by Kadry and co - workers  [37], using a  Staphyloccous epidermidis   wild strain,  isolated from a patient with endophtalmitis; the  authors reported the ability of hyaluronan to reduce  bacterial adhesion to IOLs to ≥30%, compared with  untreated control cells. The authors suggested the use  of adjuvant therapy such as dispers ants or  anti - adhesives, in addition to the antibiotics in  irrigating solutions for bacterial ocular infections.   More recently, the  in vitro   antiadhesive and  antibiofilm activity of hyaluronic acid towards  bacterial species commonly isolated from respirator y  infections was investigated by Drago et al. [33].   In this study, the interference exerted on  bacterial adhesion was evaluated by using Hep - 2  cells, while the antibiofilm activity was assessed by  means of spectrophotometry after incubation of  biofilm with   hyaluronic acid and staining with crystal  violet.    The experimental findings clearly demonstrated  how hyaluronic acid is able to interfere with bacterial  adhesion to a cellular substrate in a  concentration - dependent manner. Moreover,  Staphylococcus aureus   biofilm was found to be more  sensitive to the action of HA, compared to that  produced by  Haemophilus influenzae   and  Moraxella  catarrhalis .    Concerning more specifically the antimicrobial  activity, HA has also been shown to exert varied  bacteriostatic, but   not bactericidal, dose - dependent  effects on different microorganisms in the planktonic  phase [31, 38].    In this regard, Radaeva et al. reported the  inhibiting activity of HA with respect to some  Pseudomonas   species [39], while Ardizzoni and  co - workers [30 ] investigated the effects of HA on 15  ATCC bacterial strains, representative of clinically  relevant bacterial and fungal species. Their results  showed that different microbial species and,  sometimes, different strains belonging to the same  species, are di fferently affected by HA. In particular,  staphylococci, enterococci,  Streptococcus mutans , two  Escherichia coli   strains,  Pseudomonas aeruginosa ,  Candida  glabrata   and  C. parapsilosis   displayed a HA  dose - dependent growth inhibition, while no HA  effects were  detected in  E. coli   ATCC 13768 and  C.  Albicans   and  S. sanguinis   was favoured by the highest  HA dose.    Comparing the potential bacteriostatic effect of  some of the most commonly used biomatrix materials  (collagen type I, hyaluronic acid, hydroxyapatite,  pol ylactic acid and polyglycolic acid) on the growth  over the first 12h of exposure of some of the most  common orthopaedic bacterial pathogens  ( Staphylococcus aureus, Staphylococcus epidermidis,  β - hemolytic Streptococcus, Pseudomonas aeruginosa) ,  Carlson and  co - workers [38] found that HA had the  most significant bacteriostatic properties on the  studied organisms. None of the materials exhibited a  purely bactericidal effect on the bacterial strains  studied.   Pirnazar et al. [31] investigated the potential  bacter iostatic effect of hyaluronic acid in different  concentrations and molecular weight on oral and  non - oral microorganisms ( Staphylococcus aureus,  Propionibacterium acnes, Actinobacillus  actinomycetemcomitans, Pavotella oris   and  Porphyromonas gingivalis ) with   potential application in  dentistry surgery; The results showed that different  hyaluronan solutions exerted varied bacteriostatic  effects on all the bacterial strains. The authors  concluded that the clinical application of hyaluronan  in form of membranes,  gels, or sponges during  surgical therapy may reduce bacterial contamination  of the surgical wound, thereby lessening the risk of  postsurgical infection and promoting more  predictable regeneration.   Concerning possible orthopaedic applications, in  2004 Harri s and Richards [40] showed the  visualization and quantification of  S. aureus   adhering  to a variety of different treated/coated titanium  surfaces. In their study, coating titanium with sodium  hyaluronate significantly decreased the density of  S.  aureus   adhe ring to the surfaces and its potential use in  osteosynthesis, orthopaedics or dental applications  was suggested out.   In a very recent review on polysaccharide - based  coatings, that have been proposed over the last ten  years to impede biofilm formation on ma terial  surfaces exposed to bacterial contamination,  hyaluronic acid was discussed as one of the most  studied, with demonstrated non - fouling properties on  glass surfaces [41]; displaying hydrophilic  characteristics (contact angle of 22°), this coating was  i n fact reported to reduce adhesion of  S. epidermidis   and  E. coli   by several orders of magnitude compared  to the unmodified glass slide. Similarly, adhesion of  S.  aureus   on Ti foils functionalized with hyaluronic  acid - catechol was lower than on pristine sub strates.    Based on HA antiadhesive properties, a novel  HA - based hydrogel has been recently proposed, in  order to protect implanted biomaterials in  orthopaedics, trauma and dental surgery   from  bacterial colonization [42]; this fast - resorbable  hydrogel coati ng, composed of covalently linked  hyaluronan and poly - D,L - lactide (“Defensive  </p>
                                        
                                            <p>10.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   72     Carlson GA, Dragoo JL, Samimi B, Bruckner DA, Bernard GW, Hedrick M, et  al. Bacteriostatic  properties of biomatrices against common orthopaedic  pathogens. Biochem Biophys Res Commun 2004; 321:472 – 8.     Drago L, Cappelletti L, De Vecchi E, Pignataro L, Torretta S, Mattina R.  Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria  r esponsible for respiratory tract infections. APMIS. 2014 Oct;122(10):1013 - 9.     Pavesio   A, Renier D, Cassinelli C, Morra M.   Anti - adhesive surfaces through  hyaluronan coatings. Med Device Technol.  1997   Sep;8(7):20 - 1, 24 - 7.     Morra M, Cassineli C.   Non - fouling pro perties of polysaccharide - coated  surfaces. J Biomater Sci Polym Ed. 1999;10(10):1107 - 24.     Cassinelli C, Morra M,  Pavesio   A, Renier D. Evaluation of interfacial  properties of hyaluronan coated poly(methylmethacrylate) intraocular lenses.  J Biomater Sci Polym   Ed. 2000;11(9):961 - 77.     Kadry AA, Fouda SI, Shibl AM, Abu El - Asrar AA. Impact of slime dispersants  and anti - adhesives on in vitro biofilm formation of Staphylococcus  epidermidis on intraocular lenses and on antibiotic activities. J Antimicrob  Chemother. 20 09 Mar;63(3):480 - 4.     Carlson GA, Dragoo JL, Samimi B, Bruckner DA, Bernard GW, Hedrick M,  Benhaim P. Bacteriostatic properties of biomatrices against common  orthopaedic pathogens. Biochem Biophys Res Commun. 2004 Aug  20;321(2):472 - 8.     Radaeva IF, Kostina GA,   Il'ina SG, Kostyleva RN .   Antimicrobial activity of  hyaluronic acid .   Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii  2001 ; :74 - 75 .     Harris LG, Richards RG. Staphylococcus aureus adhesion to different treated  titanium surfaces. J Mater Sci Mater Med. 2 004 Apr;15(4):311 - 4.     Junter GA, Thébault P, Lebrun L .   Polysaccharide - based antibiofilm surfaces.  Acta Biomater. 2016 Jan;30:13 - 25.      Pitarresi G, Palumbo FS, Calascibetta F, Fiorica C, Di Stefano M,  Giammona   G .   Medicated hydrogels of  hyaluronic   acid derivat ives for use in orthopedic field.  Int J Pharm. 2013 Jun 5;449(1 - 2):84 - 94. doi: 10.1016/j.ijpharm.2013.03.059.  Epub 2013 Apr 12.     Drago L, Boot W, Dimas K, Malizos K, Hänsch GM, Stuyck J,   Gawlitta D,  Romanò CL.  Does implant coating with antibacterial - loaded  hydrogel reduce  bacterial colonization and biofilm formation in vitro?  Clin Orthop Relat Res .  2014 Nov;472(11):3311 - 23.     Cloutier M, Mantovani D, Rosei F. Antibacterial Coatings: Challenges,  Perspectives, and Opportunities. Trends Biotechnol. 2015 Nov;33(11 ):637 - 52.     Torretta S, Marchisio P, Rinaldi V, Gaffuri M, Pascariello C,  Drago   L, Baggi E,  Pignataro L. Topical administration of  hyaluronic acid   in children with  recurrent or chronic middle ear inflammations. Int J Immunopathol  Pharmacol. 2016 Sep;29(3):438 - 42.     Damiano   R,  Cicione   A. The role of sodium hyaluronate and sodium  chondroitin sulphate in the management of bladder disease. Ther Adv Urol.  2011 Oct;3(5):223 - 32.     Constantinides C, Manousakas T, Nikolopoulos P, Stanitsas A, Haritopoulos  K, Giannopoulos A .   Prevention of recurrent bacterial cystitis by intravesical  administration of hyaluronic acid: a pilot study. BJU Int 2004;93(9):1262 – 1266.     Sh ao Y, Shen ZJ, Rui WB, Zhou WL .   Intravesical instillation of hyaluronic acid  prolonged the effect of bladder hydrodistention in patients with severe  interstitial cystitis. Urology 2010;75 (3):547 – 550.     Lipovac   M., Kurz   C., Reithmayr   F.,  et al .   Prevention of   recurrent bacterial  urinary tract infections by intravesical instillation of hyaluronic acid. Int J  Gynaecol Obstet  2007 ;  96: 192 - 195.     Damiano   R., Quarto   G., Bava   I.,    et al. Prevention of recurrent urinary tract  infections by intravesical administration  of hyaluronic acid and chondroitin  sulphate: a placebo - controlled randomised trial. Eur Urol  2011 ; 59: 645 - 651.     Ciani O, Arendsen E, Romancik M, Lunik R, Costantini E, Di Biase M, Morgia  G, Fragalà E, Roman T, Bernat M, Guazzoni G, Tarricone R, Lazzeri M.  I ntravesical administration of combined hyaluronic acid (HA) and chondroitin  sulfate (CS) for the treatment of female recurrent urinary tract infections: a  European multicentre nested case - control study. BMJ Open. 2016 Mar  31;6(3):e009669.     Johannsen A, Tell efsen M, Wikesjö U, Johannsen G. Local delivery of  hyaluronan as an adjunct to scaling and root planing in the treatment of  chronic periodontitis. J Periodontol. 2009 Sep;80(9):1493 - 7.     Sapna N, Vandana KL.   Evaluation of hyaluronan gel (Gengigel(®) ) as a  t opical applicant in the treatment of gingivitis. J Investig Clin Dent. 2011  Aug;2(3):162 - 70.     Eick S, Renatus A, Heinicke M, Pfister W, Stratul SI, Jentsch H.  Hyaluronic   Acid as an adjunct after scaling and root planing: a prospective randomized  clinical tr ial. J Periodontol. 2013 Jul;84(7):941 - 9.     Harris LG, Richards RG. Staphylococci and implant surfaces: a review.   Injury .  2006 May;37  ( Suppl 2 ) :S3 - 14.     Hynes WL, Walton SL. Hyaluronidases of gram - positive bacteria. FEMS  Microbiol Lett 2000;183:201 – 7.      Barton  AJ, Sagers RD, Pitt WG.   Bacterial adhesion to orthopedic implant  polymers. J Biomed Mater Res. 1996 Mar;30(3):403 - 10.     Birkenhauer   E, Neethirajan S, Weese JS .   Collagen and hyaluronan at  wound   sites influence early polymicrobial biofilm adhesive events. BMC  Microbiol.  2014 Jul 16;14:191.     Matsuno H, Yudoh K, Hashimoto M, Himeda Y, Miyoshi T, Yoshida K, Kano  S. Antibiotic - containing hyaluronic acid gel as an antibacterial carrier:  Usefulness of sponge and film - formed HA gel in deep infection. J Orthop Res.  2006   Mar;24(3):321 - 6.     Matsuno H, Yudoh K, Hashimoto M, Himeda Y, Miyoshi T, Yoshida K, Kano  S. A new antibacterial carrier of hyaluronic acid gel. J Orthop Sci. 2006  Oct;11(5):497 - 504.     Giavaresi   G, Meani E, Sartori M, Ferrari A, Bellini D, Sacchetta AC, Meraner J,  Sambri A, Vocale C, Sambri V, Fini M, Romanò CL. Efficacy of  antibacterial - loaded coating in an in vivo model of acutely highly  contaminated implant. Int Orthop. 2014 Jul;38(7):1505 - 12.     Romanò CL, Malizos K,   Capuano N, Mezzoprete R, D’Arienzo M, Van Der  Straeten C, Scarponi S, Drago L.     Does an antibiotic - loaded hydrogel coating  reduce early post - surgical infection after joint arthroplasty ? J Bone Joint .   2016   </p>
                                        
                                            <p>9.   J .   Bone Joint Infect .   20 1 7 ,  Vol.  2     http://www. jbji.net   71   Conclusion   Although to date no surface modification has  been reported to be able to fully prevent bacterial  adhesion and biofilm formation [55], available data  show that hyaluronic acid has a proven   in vitro   antiadhesive/antibiofilm effect against some of the  most common pathogens and it has been used safely,  alone or in combination with other polymers, with  satisfactory results in different conditions associated  with biofilm - related chronic infectio ns.   Clinical data in various applications, including  dentistry, urology, wound management, dermatology  and orthopedics, allow to consider the potential use of  HA as a protective coating barrier of implants  particularly safe and feasible on a large scale ba sis.   While antibacterial coatings to mitigate the  occurrence of implant -   and biofilm - related infections  are regarded as one of the most needed technology,  currently only few and insufficient options are  available for clinical use in orthopedics and trauma  surgery [18].    Considering the pathogenesis of implant - related  infections, any protection offered by a fully  biocompatible antiadhesive barrier, like HA and some  of its derivatives, could be extremely useful to reduce  the tremendous burden of implant - relat ed infections.   On the other  hand,   it should be noted that  hyaluronic acid as a passive protective barrier has  some limits. Among others, the  antiadhesive/antibiofilm effect is limited and may  vary, depending on the type of the microorganism,  the bacterial  load, the local environment, etc.;  moreover, HA protection may be neutralized by the  possible ability of some bacteria to produce  hyaluronidase, an enzyme that catalyzes the  degradation of hyaluronic acid [56], while collagen  and hyaluronan may even become   possible ligands  for microbial attachment in particular situations [57,  58].    To overcome at least some of these limits,  possible loading of hyaluronic - based hydrogels with  antibiotics is technically feasible and has been  proposed by different authors [59   –   62], being a  possible option for future developments and large  scale clinical applications, provided that regulatory  requirements can be met.   Co mpeting   Interest s   The authors have declared that no competing  interest exists .   References     Roemling U, Balsalo bre C. Biofilm infections, their resilience to therapy and  innovative treatment strategies. J Intern Med 2012;272:541 – 61.     Romanò CL, Romanò D, Logoluso N, Drago L. Bone and joint infections in  adults: a comprehensive classification proposal. European  orthopaedics and  traumatology. 2011;1(6):207 - 17.     Poultsidis L ,   Liaropoulos L., Malizos KN.   The socioeconomic burden of  musculoskeletal infections. JBJS Am  2010 ; 92: 13.     Romanò C.L., Romanò D., Logoluso N., Meani E.   Septic versus aseptic hip  revision: how different ? J Orthop Traumatol.  2010 ; 11(3):167 - 174.     Drago L, Lidgren L, Bottinelli E, Villafañe JH, Berjano P, Banfi G, Romanò CL,  Sculco TP.   Mapping of microbiological procedures by the members of the  International  Society of Orthopaedic Centers (ISOC) for periprosthetic  infections diagnosis.  J Clin Microbiol . 2016 Mar 2. pii: JCM.00155 - 16.     Cats - Baril W, Gehrke T, Huff K, Kendoff D, Maltenfort M, Parvizi J.  International consensus on periprosthetic joint infection: d escription of the  consensus process. Clin Orthop Relat Res. 2013;471:4065 – 75.     Kamath AF, Ong KL, Lau E, Chan V, Vail TP, Rubash HE, et al. Quantifying  the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection.  The Journal of arthroplasty . 2015;30(9):1492 - 7.     Gristina AG, Naylor P, Myrvik Q. Infections from biomaterials and implants: a  race for the surface. Med Prog Technol 1988;14(3 - 4):205 - 24.     Gristina AG, Shibata Y, Giridhar G, Kreger A, Myrvik QN. The glycocalyx,  biofilm, microbes, and r esistant infection. Semin Arthroplasty 1994;5(4):160 - 70.     Dastgheyb S, Parvizi J, Shapiro IM, Hickok NJ, Otto M .   Effect of Biofilms on  Recalcitrance of Staphylococcal Joint Infection to Antibiotic Treatment. J Inf  Dis 2015;211:641 – 50     Hake ME, Young H, Hak D J, Stahel PF, Hammerberg EM, Mauffrey C. Local  antibiotic therapy strategies in orthopaedic trauma: Practical tips and tricks  and review of the literature. Injury 2015;46(8):1447 - 56.     Gristina AG. Biomaterial - centered infection: microbial adhesion versus ti ssue  integration. Science 1987;237(4822):1588 - 95.     Busscher HJ, van der Mei HC. How do bacteria know they are on a surface and  regulate their response to an adhering state? PLoS pathogens.  2012;8(1):e1002440     Wagner C, Aytac S, Hansch GM. Biofilm growth on i mplants: bacteria prefer  plasma coats. The International journal of artificial organs. 2011;34(9):811 - 7.     Wang Y, Subbiahdoss G, de Vries J, Libera M, van der Mei HC, Busscher HJ.  Effect of adsorbed fibronectin on the differential adhesion of osteoblast - lik e  cells and Staphylococcus aureus with and without fibronectin - binding  proteins. Biofouling. 2012;28(9):1011 - 21     Laverty G, Gorman SP, Gilmore BF. Biomolecular mechanisms of  staphylococcal biofilm formation. Future microbiology. 2013;8(4):509 - 24.     Busscher H J, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJ,  Zaat SA, et al. Biomaterial - associated infection: locating the finish line in the  race for the surface. Science translational medicine. 2012;4(153):153rv10.       Romanò CL, Scarponi S, Gallazzi E,  Romanò D, Drago L .  Antibacterial coating  of implants in orthopaedics and trauma: a classification proposal in an  evolving panorama .   J Orthop Surg Res. 2015; 10: 157.     Zhang F, Zhang Z, Zhu X, Kang ET, Neoh KG. Silk - functionalized titanium  surfaces for enhan cing osteoblast functions and reducing bacterial adhesion.  Biomaterials. 2008;29:4751 – 9.     Harris LG, Tosatti S, Wieland M, Textor M, Richards RG. Staphylococcus  aureus adhesion to titanium oxide surfaces coated with non - functionalized  and peptide - functional ized poly(L - lysine) - grafted - poly(ethylene glycol)  copolymers. Biomaterials. 2004;25:4135 – 48.     Kaper HJ, Busscher HJ, Norde W. Characterization of poly(ethylene oxide)  brushes on glass surfaces and adhesion of Staphylococcus epidermidis. J  Biomat Sci Polym E d. 2003;14:313 – 24.     Oh S, Moon KS, Lee SH. Effect of RGD peptide - coated TiO2 nanotubes on the  attachment, proliferation, and functionality of bone - related cells. J  Nanomaterials. 2013;2013:1 – 11.     Zhu H, Guo Z, Liu W. Adhesion behaviors on superhydrophobic su rfaces.  Chem Commun (Camb). 2014;18:3900 – 13.     Braem A, van Mellaert L, Mattheys T, Hofmans D, de Waelheyns E, Geris L, et  al. Staphylococcal biofilm growth on smooth and porous titanium coatings for  biomedical applications. J Biomed Mater Res A. 2013, doi:1 0.1002/jbm.a.34688.     Swartjes J, Sharma PK, van Kooten TG et al.   Current developments in  antimicrobial surface coatings for biomedical application. Curr Med Chem  2015;22:2116 - 29     Moriarty TF, Grainger DW, Richards RG. Challenges in linking preclinical  anti - m icrobial research strategies with clinical outcomes for device - associated  infections. European cells &amp; materials. 2014;28:112 - 28.     Leach J.B., Schmidt C.E. Hyaluronan. Encyclo pedia of Biomaterials and  Biomedical Engineering. Marcel Dekker, New York.  2004: 7 79 – 789.     Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan:  pharmaceutical characterization and drug delivery. Drug Delivery  2005;12:327 – 42.     Volpi N, Schiller J, Stern R, Solt_es L. Role, metabolism, chemical  modifications and applications of hya luronan. Curr Med Chem  2009;16:1718 – 45.     Ardizzoni A, Neglia RG, Baschieri MC, Cermelli C, Caratozzolo M, Righi E, et  al. Influence of hyaluronic acid on bacterial and fungal species, including  clinically relevant opportunistic pathogens. J Mater Sci Mater  Med  2011;22:2329 – 38.     Pirnazar P, Wolinsky L, Nachnani S, Haake S, Pilloni A, Bernard GW.  Bacteriostatic effects of hyaluronic acid. J Periodontol 1999;70:370 – 4.   </p>
                                        
                                            <p></p>
                                        
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="statistic" slide-url="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html">
                                    <div class="row">
                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Nézetek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">1310</span>
                                                    <i class="fa fa-play"></i> Total Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">994</span>
                                                    <i class="fa fa-circle-o"></i> Website Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">316</span>
                                                    <i class="fa fa-code"></i> Embedded Views
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Műveletek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="total-share">0</span>
                                                    <i class="fa fa-share-alt"></i> Social Shares
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-up"></i> Likes
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-down"></i> Nemkedvelések
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-comments-o"></i> Comments
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Share count</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="facebook-badge">0</span>
                                                    <i class="fa fa-facebook-square"></i> Facebook
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="twitter-badge">0</span>
                                                    <i class="fa fa-twitter-square"></i> Twitter
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="linkedin-badge">0</span>
                                                    <i class="fa fa-linkedin-square"></i> LinkedIn
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="google-badge">0</span>
                                                    <i class="fa fa-google-plus-square"></i> Google+
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                    <div class="row">
                                        <div class="col-lg-12">
                                            <h4 class="mt0"> Embeds
                                                <span class="badge badge-pill float-right">
                                                    3
                                                </span>
                                            </h4>
                                            <ul class="list-group" style="height: 150px;overflow: auto;">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">25</span>
                                                    hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">3</span>
                                                    www.hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">2</span>
                                                    odoo.hbs.hu
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="col-xl-4 col-lg-4 col-md-12 col-12">
                    <ul class="nav nav-tabs" role="tablist">
                        <li class="nav-item"><a aria-controls="related" href="#related" class="nav-link active" data-toggle="tab">Kapcsolódó</a></li>
                        <li class="nav-item"><a aria-controls="most_viewed" href="#most_viewed" class="nav-link" data-toggle="tab">Most Viewed</a></li>
                    </ul>
                    <div class="tab-content">
                        <div role="tabpanel" id="related" class="tab-pane active mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1558 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1503 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/19/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html"><h6 class="mb-1">Cikk a Neurourology and Urodynamics-ban 2018.</h6></a>
            <small class="text-muted">
                1472 Views . <timeago class="timeago" datetime="2019-10-31 13:28:23.618732"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1497 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-diagnostic-algorhytm-21.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/21/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-diagnostic-algorhytm-21.html"><h6 class="mb-1">IC-BPS diagnostic algorhytm.</h6></a>
            <small class="text-muted">
                1487 Views . <timeago class="timeago" datetime="2019-10-31 13:29:57.450898"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="glycosaminoglycan-therapy-for-bladder-diseases-22.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/22/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="glycosaminoglycan-therapy-for-bladder-diseases-22.html"><h6 class="mb-1">Glycosaminoglycan Therapy for Bladder Diseases</h6></a>
            <small class="text-muted">
                1384 Views . <timeago class="timeago" datetime="2019-10-31 13:30:10.980936"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="essic-2017-budapest-abstracts-23.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/23/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="essic-2017-budapest-abstracts-23.html"><h6 class="mb-1">ESSIC 2017 Budapest abstracts</h6></a>
            <small class="text-muted">
                1463 Views . <timeago class="timeago" datetime="2019-10-31 13:30:38.129948"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/24/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html"><h6 class="mb-1">Prevalence of Symptoms of Bladder Pain Syndrome 2011</h6></a>
            <small class="text-muted">
                1303 Views . <timeago class="timeago" datetime="2019-10-31 13:30:57.131521"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/25/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html"><h6 class="mb-1">The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. 2017</h6></a>
            <small class="text-muted">
                1361 Views . <timeago class="timeago" datetime="2019-10-31 13:35:55.689470"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/26/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html"><h6 class="mb-1">Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. 2016</h6></a>
            <small class="text-muted">
                1298 Views . <timeago class="timeago" datetime="2019-10-31 13:36:14.959707"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/27/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html"><h6 class="mb-1">PENTOSAN POLYSULFATE SODIUM FOR THERAPY of IC Urology 1990</h6></a>
            <small class="text-muted">
                1413 Views . <timeago class="timeago" datetime="2019-10-31 13:37:27.415502"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/28/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html"><h6 class="mb-1">Interstitial cystitis intravesical therapy tau-06-S2-S171 2017</h6></a>
            <small class="text-muted">
                1367 Views . <timeago class="timeago" datetime="2019-10-31 13:38:04.204366"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/29/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html"><h6 class="mb-1">Novel targeted bladder drug-delivery systems rru-7-169 2015</h6></a>
            <small class="text-muted">
                1488 Views . <timeago class="timeago" datetime="2019-10-31 13:38:18.425299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/30/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html"><h6 class="mb-1">Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections 2016 bmjopen-2015-009669</h6></a>
            <small class="text-muted">
                1220 Views . <timeago class="timeago" datetime="2019-10-31 13:38:52.835202"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/31/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html"><h6 class="mb-1">Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections- Results from a multicentre survey.cuaj-9-10-e721</h6></a>
            <small class="text-muted">
                1387 Views . <timeago class="timeago" datetime="2019-10-31 13:39:08.628954"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/32/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html"><h6 class="mb-1">IC_BPS and glycosaminoglycans replacement therapy 2015 tau-04-06-638</h6></a>
            <small class="text-muted">
                1250 Views . <timeago class="timeago" datetime="2019-10-31 13:39:22.993300"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/33/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html"><h6 class="mb-1">Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans- an update on the evidence 2016 Urology</h6></a>
            <small class="text-muted">
                1388 Views . <timeago class="timeago" datetime="2019-10-31 13:40:52.836690"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/35/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html"><h6 class="mb-1">Evidence-based criteria for the pain of IC_BPS in women 2008 nihms43157</h6></a>
            <small class="text-muted">
                1299 Views . <timeago class="timeago" datetime="2019-10-31 13:45:59.326213"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/36/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html"><h6 class="mb-1">Intravesical Glycosaminoglycan Replacement with Chondroitin_2015_Article_306</h6></a>
            <small class="text-muted">
                1357 Views . <timeago class="timeago" datetime="2019-10-31 13:46:19.773972"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulphate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-bmjopen-2015-009669-37.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/37/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulphate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-bmjopen-2015-009669-37.html"><h6 class="mb-1">Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulphate (CS) for the treatment of female recurrent urinary tract infections- bmjopen-2015-009669</h6></a>
            <small class="text-muted">
                1239 Views . <timeago class="timeago" datetime="2019-10-31 13:46:36.042595"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                        <div role="tabpanel" id="most_viewed" class="tab-pane  mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="sugarvedo-ruhazat-ismerteto-3.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/3/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="sugarvedo-ruhazat-ismerteto-3.html"><h6 class="mb-1">Sugárvédő ruházat ismertető</h6></a>
            <small class="text-muted">
                3284 Views . <timeago class="timeago" datetime="2018-10-20 14:31:25.547995"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="op-set-system-5.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/5/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="op-set-system-5.html"><h6 class="mb-1">OP Set System</h6></a>
            <small class="text-muted">
                3044 Views . <timeago class="timeago" datetime="2018-11-16 13:38:03.543744"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kompresszios-polya-felhelyezese-8.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/8/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kompresszios-polya-felhelyezese-8.html"><h6 class="mb-1">Kompressziós pólya felhelyezése</h6></a>
            <small class="text-muted">
                2846 Views . <timeago class="timeago" datetime="2018-11-16 13:39:25.884480"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kotszer-polya-l-r-6.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/6/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kotszer-polya-l-r-6.html"><h6 class="mb-1">Kötszer Pólya L&amp;R</h6></a>
            <small class="text-muted">
                2643 Views . <timeago class="timeago" datetime="2018-11-16 13:38:35.611223"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="nedves-sebkezeles-flyer-l-r-7.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/7/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="nedves-sebkezeles-flyer-l-r-7.html"><h6 class="mb-1">Nedves sebkezelés flyer L&amp;R</h6></a>
            <small class="text-muted">
                2438 Views . <timeago class="timeago" datetime="2018-11-16 13:38:59.835920"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-liner-10.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/10/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-liner-10.html"><h6 class="mb-1">PDB_Actico UlcerSys Liner</h6></a>
            <small class="text-muted">
                2324 Views . <timeago class="timeago" datetime="2018-11-16 13:39:54.728282"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-2.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/2/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-2.html"><h6 class="mb-1">SciCan STATIM G4</h6></a>
            <small class="text-muted">
                2321 Views . <timeago class="timeago" datetime="2018-10-20 14:10:02.671163"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-9.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/9/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-9.html"><h6 class="mb-1">PDB_Actico UlcerSys</h6></a>
            <small class="text-muted">
                2209 Views . <timeago class="timeago" datetime="2018-11-16 13:39:42.488113"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-hasznalati-utmutato-v1-1-12.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/12/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-hasznalati-utmutato-v1-1-12.html"><h6 class="mb-1">UroStill_hasznalati_utmutato_v1.1</h6></a>
            <small class="text-muted">
                2038 Views . <timeago class="timeago" datetime="2019-10-31 13:22:24.531510"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="koronavirus-jarvany-61.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/61/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="koronavirus-jarvany-61.html"><h6 class="mb-1">KORONAVIRUS JARVANY</h6></a>
            <small class="text-muted">
                1773 Views . <timeago class="timeago" datetime="2020-04-09 15:16:22.317496"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-1.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/1/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-1.html"><h6 class="mb-1">SciCan Statim G4</h6></a>
            <small class="text-muted">
                1708 Views . <timeago class="timeago" datetime="2018-10-20 14:09:31.661802"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="new-aiding-device-for-self-instillation-v2-16.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/16/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="new-aiding-device-for-self-instillation-v2-16.html"><h6 class="mb-1">New_aiding_device_for_self-instillation_v2</h6></a>
            <small class="text-muted">
                1690 Views . <timeago class="timeago" datetime="2019-10-31 13:23:48.863175"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kitpack-11.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/11/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="kitpack-11.html"><h6 class="mb-1">Kitpack</h6></a>
            <small class="text-muted">
                1684 Views . <timeago class="timeago" datetime="2018-11-16 14:52:39.736537"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="icbps-szoszedet-14.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/14/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="icbps-szoszedet-14.html"><h6 class="mb-1">ICBPS_SZÓSZEDET</h6></a>
            <small class="text-muted">
                1618 Views . <timeago class="timeago" datetime="2019-10-31 13:23:06.826135"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/15/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html"><h6 class="mb-1">IC - FAQ-s and appropriate answers Mumbai 2019</h6></a>
            <small class="text-muted">
                1612 Views . <timeago class="timeago" datetime="2019-10-31 13:23:19.219912"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-users-manual-v1-1-13.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/13/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-users-manual-v1-1-13.html"><h6 class="mb-1">UroStill_Users_Manual_v1.1</h6></a>
            <small class="text-muted">
                1605 Views . <timeago class="timeago" datetime="2019-10-31 13:22:47.677753"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="l-r-corporate-film-4.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/4/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="l-r-corporate-film-4.html"><h6 class="mb-1">L&amp;R Corporate Film</h6></a>
            <small class="text-muted">
                1601 Views . <timeago class="timeago" datetime="2018-11-14 15:53:51.760680"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1558 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1503 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1497 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    
                </main>
                <footer class="bg-light o_footer">
                    <div id="footer" class="oe_structure oe_structure_solo">
      <section class="s_text_block pb8 pt40">
        <div class="container">
          <div class="row" style="border-top: solid 1px #ddd; padding-top: 30px;">
            <div class="col-lg-4">
              <h5>További tartalmak</h5>
              <ul class="list-unstyled">
                <li>
                  <a href="../../blog/hirek-esemenyek-1.html" data-original-title="" title="" aria-describedby="tooltip310735">Blog</a>
                  <br/>
                  <a href="../../adatkezelesi-tajekoztato.html">Adatkezelési tájékoztató</a>
                </li>
                <li>
                  <br/>
                </li>
              </ul>
            </div>
            <div class="col-lg-4" id="connect">
              <h5>Elérhetőségek</h5>
              <ul class="list-unstyled">
                <li>
                  <i class="fa fa-phone"></i>
                  <span data-note-id="2">+36 1 452 1700</span>
                </li>
                <li>
                  <i class="fa fa-envelope"></i>
                  <span><a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="2e474048416e464c5d00465b">[email&#160;protected]</a></span>
                </li>
              </ul>
              <p> </p>
            </div>
            <div class="col-lg-4">
              <h5>
                <span>HBS Medical</span>
                <small> – <a href="../../aboutus.html" data-original-title="" title="" aria-describedby="tooltip425138">Kapcsolat</a></small>
              </h5>
              <p>&nbsp;<br/></p>
            </div>
          </div>
        </div>
      </section>
    </div>
  <div class="o_footer_copyright">
            <div class="container">
                <div class="row">
                    <div class="col-lg-6 text-muted text-center text-md-left">
                        <span>Copyright &copy;</span> <span itemprop="name">HBS Medical</span>
                        
    

                    </div>
                    <div class="col-lg-6 text-right o_not_editable">
                        
    <div class="o_brand_promotion text-muted">
        Az oldalt készítette:
        <a href="https://eyssen.hu/" target="_blank"><img src="../../web/image/606/eyssen_logo_blue.png" width="120"/></a>
    </div>

                    </div>
                </div>
            </div>
        </div>
    </footer>
            </div>
        <script data-cfasync="false" src="../../cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script id="tracking_code">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

            ga('create', _.str.trim('UA-52898474-1'), 'auto');
            ga('send','pageview');
        </script>
    
        
            </body>
        
<!-- Mirrored from hbs.hu/slides/slide/hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 16:04:26 GMT -->
</html>
    
    
